United States · FDA National Drug Code directory
HEPLISAV-B
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-4526_bc19aced-d2fa-4b4f-8824-e15a56fe422d
- Product NDC
- 50090-4526
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Hepatitis B Vaccine (Recombinant) Adjuvanted
- Labeler
- A-S Medication Solutions
- Marketing category
- BLA
- Marketing start / end (source format)
- 20180101
- Source listing expiry
- 20261231
Source-listed ingredients
- HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN — 20 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 SYRINGE in 1 CARTON (50090-4526-0) / .5 mL in 1 SYRINGE (50090-4526-1) · 50090-4526-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →